Companion Animal Veterinary Vaccines Global Market Report 2023

Description

“Companion Animal Veterinary Vaccines Global Market Report 2023 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on companion animal veterinary vaccines market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
Measure the impact of high global inflation on market growth.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for companion animal veterinary vaccines ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The companion animal veterinary vaccines market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

1) By Product: Inactivated; Live Attenuated; Recombinant; Other Products

2) By Route Of Administration: Oral; Parenteral; Other Routes Of Administration

3) By Distribution Channel: Veterinary Hospitals; Veterinary Clinics; Pharmacies And Drug Stores; Other Distribution Channels

Companies Mentioned: Boehringer Ingelheim; Eli Lilly and Company (Elcano); Heska Co.; Merck Animal Health; Virbac

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Major players in the companion animal veterinary vaccines market are: Boehringer Ingelheim, Eli Lilly and Company (Elcano), Heska Co., Merck Animal Health, Virbac, Zoetis, ElancoCevaSante Animal S.A., Bayer Healthcare, NEOGEN CORPORATION, and ImmuCell Corporation.

The global companion animal veterinary vaccines market will grow from $3.25 billion in 2022 to $3.47 billion in 2023 at a compound annual growth rate (CAGR) of 6.7%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, surge in commodity prices, and supply chain disruptions, causing inflation across goods and services effecting many markets across the globe. The companion animal veterinary vaccines market is expected to grow to $4.48 billion in 2027 at a CAGR of 6.6%.

The companion animal veterinary vaccine market consists of sales of toxoid vaccines, viral vector vaccines, messenger RNA vaccines, and conjugated vaccines. Values in this market are: 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

Companion animal vaccines are substances that are used to stimulate the production of antibodies and provide immunity against one or several diseases in pets such as dogs, birds, and cats. They are also used to improve food digestion, enhance immunity, enable animals to gain fat and weight, and generate good quality meat that is harvested for commercial purposes.

North America was the largest region in the companion animal veterinary vaccines market in 2022. Asia-Pacific was the second-largest region in the companion animal veterinary vaccines market. The regions covered in the companion animal veterinary vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

The main products of companion animal veterinary vaccines are inactivated, live attenuated, recombinant, and other products. A recombinant vaccine is one that was created using recombinant DNA technology. This entails inserting DNA encoding an antigen (such as a bacterial surface protein) that triggers an immunological response into bacterial or mammalian cells, expressing the antigen in these cells, and then purifying it from them. The products are administered through oral, parenteral, and other routes of administration and are distributed through veterinary hospitals, veterinary clinics, pharmacies, drug stores, and other distribution channels.

Increased pet ownership by Gen X and Gen Y adults contributed to the growth of the companion animal veterinary vaccine market during the historic period. According to the APPA, millennials, or Gen Y, represent the largest segment of pet owners for all types of pets. More than 80% of Gen Y and Gen Z own a dog, and 50% or less own a cat as a pet. Multiple pet ownership is also on the rise in some parts of the world. According to the 2019-2020 APPA National Pet Owners Survey, 67% of US households own pets, which is equal to 84.9 million homes. Pet owners are well aware of advanced facilities and are willing to spend a large amount of money on the health of their pets. Therefore, the rise in pet ownership aids in the growth of the companion animal veterinary vaccine market.

The high cost of veterinary vaccines is expected to restrain the growth of the market. According to data from Harris Interactive, in the USA, households with pets spend about $1,000 on pet care. There are around 70% of households in the USA who own a pet and only 39% have enough in their savings to cover high spending related to pet care. According to a report by PET IQ, in the USA, nearly 28% of households experienced barriers to veterinary care in the past two years. 80% of pet owners are unable to obtain preventative care due to financial constraints. There are several instances when it happens that the pet owners cannot afford expensive animal treatment and this factor restrained the growth of the companion animal veterinary vaccines market. Usually, the average cost of the rabies vaccine varies, typically from about $1,200 to $6,500. Thus, the high cost of companion animal veterinary vaccines will restrain the growth of the market over the forecast period.

Companies in the companion animal veterinary vaccine industry are increasingly collaborating and partnering with other players to drive product innovations. To succeed in the increasingly competitive veterinary market, companion animal veterinary vaccine companies are entering into new geographies and developing innovative products through sharing skills and expertise with other players. For instance, Merck & Co.'s subsidiary MSD Animal Health announced a strategic partnership with Vinovo B.V., a division of Viscon Hatchery Automation, the leading hatchery automation company, to provide a new standard in safe and effective Vinovo vaccination to improve bird welfare and reduce vaccine reactions.

In February 2020, Zoetis, Inc., a US-based animal health company specializing in the discovery, development, production, and marketing of animal health drugs, acquired Ethos Diagnostic Science for an undisclosed amount. Through this acquisition, Zoetis continues to expand its diagnostics presence in order to provide American veterinarians with comprehensive services at an improved value. Ethos Diagnostic Science is a US-based veterinary diagnostic company pioneering in various types of diagnostic testing and clinical chemistry.

The countries covered in the companion animal veterinary vaccines market are: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA.

The market value is defined as the revenues that enterprises gain from goods and/or services sold within the specified market and geography through sales, grants, or donations in terms of currency (in USD ($) unless otherwise specified).

The revenues for a specified geography are consumption values - that is, they are revenues generated by organizations in the specified geography within the specified market, irrespective of where they are produced. It does not include revenues from resales either further along the supply chain or as part of other products.

The companion animal veterinary vaccines research report is one of a series of new reports from The Business Research Company that provides companion animal veterinary vaccines statistics, including companion animal veterinary vaccines industry global market size, regional shares, competitors with companion animal veterinary vaccines share, detailed companion animal veterinary vaccines segments, market trends and opportunities, and any further data you may need to thrive in the companion animal veterinary vaccines industry. This companion animal veterinary vaccines research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Product Code: r2520

1. Executive Summary

2. Companion Animal Veterinary Vaccines Market Characteristics

3. Companion Animal Veterinary Vaccines Market Trends And Strategies

4. Companion Animal Veterinary Vaccines Market - Macro Economic Scenario

4.1 COVID-19 Impact On Companion Animal Veterinary Vaccines Market

4.2 Ukraine-Russia War Impact On Companion Animal Veterinary Vaccines Market

4.3 Impact Of High Inflation On Companion Animal Veterinary Vaccines Market

5. Companion Animal Veterinary Vaccines Market Size And Growth

5.1. Global Companion Animal Veterinary Vaccines Historic Market, 2017-2022, $ Billion
- 5.1.1. Drivers Of The Market
- 5.1.2. Restraints On The Market
5.2. Global Companion Animal Veterinary Vaccines Forecast Market, 2022-2027F, 2032F, $ Billion
- 5.2.1. Drivers Of The Market
- 5.2.2. Restraints On the Market

6. Companion Animal Veterinary Vaccines Market Segmentation

6.1. Global Companion Animal Veterinary Vaccines Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Inactivated
Live Attenuated
Recombinant
Other Products
6.2. Global Companion Animal Veterinary Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Oral
Parenteral
Other Routes Of Administration
6.3. Global Companion Animal Veterinary Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Veterinary Hospitals
Veterinary Clinics
Pharmacies And Drug Stores
Other Distribution Channels

7. Companion Animal Veterinary Vaccines Market Regional And Country Analysis

7.1. Global Companion Animal Veterinary Vaccines Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
7.2. Global Companion Animal Veterinary Vaccines Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

8. Asia-Pacific Companion Animal Veterinary Vaccines Market

8.1. Asia-Pacific Companion Animal Veterinary Vaccines Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Companion Animal Veterinary Vaccines Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
8.3. Asia-Pacific Companion Animal Veterinary Vaccines Market, Segmentation By Route Of Administration:, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

9. China Companion Animal Veterinary Vaccines Market

9.1. China Companion Animal Veterinary Vaccines Market Overview
9.2. China Companion Animal Veterinary Vaccines Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion
9.3. China Companion Animal Veterinary Vaccines Market, Segmentation By Route Of Administration:, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion

10. India Companion Animal Veterinary Vaccines Market

10.1. India Companion Animal Veterinary Vaccines Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
10.2. India Companion Animal Veterinary Vaccines Market, Segmentation By Route Of Administration:, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

11. Japan Companion Animal Veterinary Vaccines Market

11.1. Japan Companion Animal Veterinary Vaccines Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
11.2. Japan Companion Animal Veterinary Vaccines Market, Segmentation By Route Of Administration:, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

12. Australia Companion Animal Veterinary Vaccines Market

12.1. Australia Companion Animal Veterinary Vaccines Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
12.2. Australia Companion Animal Veterinary Vaccines Market, Segmentation By Route Of Administration:, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

13. Indonesia Companion Animal Veterinary Vaccines Market

13.1. Indonesia Companion Animal Veterinary Vaccines Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
13.2. Indonesia Companion Animal Veterinary Vaccines Market, Segmentation By Route Of Administration:, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

14. South Korea Companion Animal Veterinary Vaccines Market

14.1. South Korea Companion Animal Veterinary Vaccines Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
14.2. South Korea Companion Animal Veterinary Vaccines Market, Segmentation By Route Of Administration:, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

15. Western Europe Companion Animal Veterinary Vaccines Market

15.1. Western Europe Companion Animal Veterinary Vaccines Market Overview
15.2. Western Europe Companion Animal Veterinary Vaccines Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
15.3. Western Europe Companion Animal Veterinary Vaccines Market, Segmentation By Route Of Administration:, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

16. UK Companion Animal Veterinary Vaccines Market

16.1. UK Companion Animal Veterinary Vaccines Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
16.2. UK Companion Animal Veterinary Vaccines Market, Segmentation By Route Of Administration:, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

17. Germany Companion Animal Veterinary Vaccines Market

17.1. Germany Companion Animal Veterinary Vaccines Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
17.2. Germany Companion Animal Veterinary Vaccines Market, Segmentation By Route Of Administration:, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

18. France Companion Animal Veterinary Vaccines Market

18.1. France Companion Animal Veterinary Vaccines Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
18.2. France Companion Animal Veterinary Vaccines Market, Segmentation By Route Of Administration:, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

19. Eastern Europe Companion Animal Veterinary Vaccines Market

19.1. Eastern Europe Companion Animal Veterinary Vaccines Market Overview
19.2. Eastern Europe Companion Animal Veterinary Vaccines Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
19.3. Eastern Europe Companion Animal Veterinary Vaccines Market, Segmentation By Route Of Administration:, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

20. Russia Companion Animal Veterinary Vaccines Market

20.1. Russia Companion Animal Veterinary Vaccines Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
20.2. Russia Companion Animal Veterinary Vaccines Market, Segmentation By Route Of Administration:, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

21. North America Companion Animal Veterinary Vaccines Market

21.1. North America Companion Animal Veterinary Vaccines Market Overview
21.2. North America Companion Animal Veterinary Vaccines Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
21.3. North America Companion Animal Veterinary Vaccines Market, Segmentation By Route Of Administration:, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

22. USA Companion Animal Veterinary Vaccines Market

22.1. USA Companion Animal Veterinary Vaccines Market Overview
22.2. USA Companion Animal Veterinary Vaccines Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
22.3. USA Companion Animal Veterinary Vaccines Market, Segmentation By Route Of Administration:, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

23. South America Companion Animal Veterinary Vaccines Market

23.1. South America Companion Animal Veterinary Vaccines Market Overview
23.2. South America Companion Animal Veterinary Vaccines Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
23.3. South America Companion Animal Veterinary Vaccines Market, Segmentation By Route Of Administration:, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

24. Brazil Companion Animal Veterinary Vaccines Market

24.1. Brazil Companion Animal Veterinary Vaccines Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
24.2. Brazil Companion Animal Veterinary Vaccines Market, Segmentation By Route Of Administration:, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

25. Middle East Companion Animal Veterinary Vaccines Market

25.1. Middle East Companion Animal Veterinary Vaccines Market Overview
25.2. Middle East Companion Animal Veterinary Vaccines Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
25.3. Middle East Companion Animal Veterinary Vaccines Market, Segmentation By Route Of Administration:, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

26. Africa Companion Animal Veterinary Vaccines Market

26.1. Africa Companion Animal Veterinary Vaccines Market Overview
26.2. Africa Companion Animal Veterinary Vaccines Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
26.3. Africa Companion Animal Veterinary Vaccines Market, Segmentation By Route Of Administration:, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

27. Companion Animal Veterinary Vaccines Market Competitive Landscape And Company Profiles

27.1. Companion Animal Veterinary Vaccines Market Competitive Landscape
27.2. Companion Animal Veterinary Vaccines Market Company Profiles
- 27.2.1. Boehringer Ingelheim
  - 27.2.1.1. Overview
  - 27.2.1.2. Products and Services
  - 27.2.1.3. Strategy
  - 27.2.1.4. Financial Performance
- 27.2.2. Eli Lilly and Company (Elcano)
  - 27.2.2.1. Overview
  - 27.2.2.2. Products and Services
  - 27.2.2.3. Strategy
  - 27.2.2.4. Financial Performance
- 27.2.3. Heska Co.
  - 27.2.3.1. Overview
  - 27.2.3.2. Products and Services
  - 27.2.3.3. Strategy
  - 27.2.3.4. Financial Performance
- 27.2.4. Merck Animal Health
  - 27.2.4.1. Overview
  - 27.2.4.2. Products and Services
  - 27.2.4.3. Strategy
  - 27.2.4.4. Financial Performance
- 27.2.5. Virbac
  - 27.2.5.1. Overview
  - 27.2.5.2. Products and Services
  - 27.2.5.3. Strategy
  - 27.2.5.4. Financial Performance

28. Key Mergers And Acquisitions In The Companion Animal Veterinary Vaccines Market

29. Companion Animal Veterinary Vaccines Market Future Outlook and Potential Analysis

30. Appendix

30.1. Abbreviations
30.2. Currencies
30.3. Historic And Forecast Inflation Rates
30.4. Research Inquiries
30.5. The Business Research Company
30.6. Copyright And Disclaimer